BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lutz B. Neurobiology of cannabinoid receptor signaling
. Dialogues Clin Neurosci 2020;22:207-22. [PMID: 33162764 DOI: 10.31887/DCNS.2020.22.3/blutz] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Stella N. THC and CBD: Similarities and differences between siblings. Neuron 2023;111:302-27. [PMID: 36638804 DOI: 10.1016/j.neuron.2022.12.022] [Reference Citation Analysis]
2 Agostini M, Favretto D, Renzoni C, Vogliardi S, Duranti A. Characterization of URB Series Synthetic Cannabinoids by HRMS and UHPLC–MS/MS. Pharmaceuticals 2023;16:201. [DOI: 10.3390/ph16020201] [Reference Citation Analysis]
3 Bernal-Chico A, Tepavcevic V, Manterola A, Utrilla C, Matute C, Mato S. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells. Glia 2023;71:103-26. [PMID: 35353392 DOI: 10.1002/glia.24172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Brierley SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, Storr M, Tack J. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome. Nat Rev Gastroenterol Hepatol 2023;20:5-25. [PMID: 36168049 DOI: 10.1038/s41575-022-00682-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Duranti A, Beldarrain G, Álvarez A, Sbriscia M, Carloni S, Balduini W, Alonso-Alconada D. The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic-Ischemic Brain Injury. Biomedicines 2022;11. [PMID: 36672536 DOI: 10.3390/biomedicines11010028] [Reference Citation Analysis]
6 Modaresi F, Talachian K. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes. Pharm Med 2022. [DOI: 10.1007/s40290-022-00447-7] [Reference Citation Analysis]
7 Brandt AL, Garai S, Zagzoog A, Hurst DP, Stevenson LA, Pertwee RG, Imler GH, Reggio PH, Thakur GA, Laprairie RB. Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.919605] [Reference Citation Analysis]
8 Navarro-Romero A, Galera-López L, Ortiz-Romero P, Llorente-Ovejero A, de Los Reyes-Ramírez L, Bengoetxea de Tena I, Garcia-Elias A, Mas-Stachurska A, Reixachs-Solé M, Pastor A, de la Torre R, Maldonado R, Benito B, Eyras E, Rodríguez-Puertas R, Campuzano V, Ozaita A. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome. Elife 2022;11:e72560. [PMID: 36217821 DOI: 10.7554/eLife.72560] [Reference Citation Analysis]
9 Tokutake T, Asano T, Miyanishi H, Nakaya S, Izuo N, Nitta A. Cannabinoid Type 1 Receptors in the Basolateral Amygdala Regulate ACPA-Induced Place Preference and Anxiolytic-Like Behaviors. Neurochem Res 2022. [PMID: 35984590 DOI: 10.1007/s11064-022-03708-8] [Reference Citation Analysis]
10 Schneider M, Müller CP, Knies AK. Low income and schizophrenia risk: a narrative review. Behav Brain Res 2022;:114047. [PMID: 35933046 DOI: 10.1016/j.bbr.2022.114047] [Reference Citation Analysis]
11 Cuddihey H, MacNaughton WK, Sharkey KA. Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis. Cell Mol Gastroenterol Hepatol 2022;14:947-63. [PMID: 35750314 DOI: 10.1016/j.jcmgh.2022.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kytikova O, Denisenko Y, Novgorodtseva T, Bocharova N, Kovalenko I. Fatty acid epoxides in the regulation of the inflammation. BIOMED KHIM 2022;68:177-189. [DOI: 10.18097/pbmc20226803177] [Reference Citation Analysis]
13 Scienza-martin K, Lotz FN, Zanona QK, Santana-kragelund F, Crestani AP, Boos FZ, Calcagnotto ME, Quillfeldt JA. Memory consolidation depends on endogenous hippocampal levels of anandamide: CB1 and M4, but possibly not TRPV1 receptors mediate AM404 effects. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.04.009] [Reference Citation Analysis]
14 Zieglgänsberger W, Brenneisen R, Berthele A, Wotjak CT, Bandelow B, Tölle TR, Lutz B. Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? Med Cannabis Cannabinoids. [DOI: 10.1159/000522432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu Y, Jia M, Wu C, Zhang H, Chen C, Ge W, Wan K, Lan Y, Liu S, Li Y, Fang M, He J, Pan HL, Si JQ, Li M. Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain. Front Pharmacol 2021;12:781237. [PMID: 35046811 DOI: 10.3389/fphar.2021.781237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Szejko N, Müller-vahl K. Cannabinoids: Possible role in the pathophysiology and therapy of Gilles de la Tourette syndrome. International Review of Movement Disorders 2022. [DOI: 10.1016/bs.irmvd.2022.04.002] [Reference Citation Analysis]
17 English A, Land B, Stella N. Impact of adolescent THC exposure on later adulthood: Focus on mesocorticolimbic function and behaviors. Cannabis and the Developing Brain 2022. [DOI: 10.1016/b978-0-12-823490-7.00010-1] [Reference Citation Analysis]
18 Martínez-Aguirre C, Cinar R, Rocha L. Targeting Endocannabinoid System in Epilepsy: For Good or for Bad. Neuroscience 2021:S0306-4522(21)00637-0. [PMID: 34923038 DOI: 10.1016/j.neuroscience.2021.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Vázquez-oliver A, Pérez-garcía S, Pizarro N, Molina-porcel L, de la Torre R, Maldonado R, Ozaita A. Long-term decreased cannabinoid type-1 receptor activity restores specific neurological phenotypes in the Ts65Dn mouse model of Down syndrome.. [DOI: 10.1101/2021.11.22.469296] [Reference Citation Analysis]
20 Deng L, Viray K, Singh S, Cravatt B, Stella N. ABHD6 Controls Amphetamine-Stimulated Hyperlocomotion: Involvement of CB1 Receptors. Cannabis Cannabinoid Res 2021. [PMID: 34705543 DOI: 10.1089/can.2021.0066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Raux PL, Drutel G, Revest JM, Vallée M. New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function. J Neuroendocrinol 2021;:e13034. [PMID: 34486765 DOI: 10.1111/jne.13034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Boczek T, Zylinska L. Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain. Int J Mol Sci 2021;22:8168. [PMID: 34360934 DOI: 10.3390/ijms22158168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Moser U. Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome? BMJ Case Rep 2021;14:e243072. [PMID: 34230048 DOI: 10.1136/bcr-2021-243072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Балезина О, Тарасова Е, Гайдуков А. Неканоническая активность эндоканнабиноидов и их рецепторов в центральных и периферических синапсах. БМ 2021;86:947-963. [DOI: 10.31857/s0320972521070010] [Reference Citation Analysis]
25 Galera-lópez L, Salgado-mendialdúa V, Moreno E, Bergadà-martínez A, Hoffman AF, Manzanares-sierra I, Busquets-garcia A, Casadó V, Lupica CR, Maldonado R, Ozaita A. A low repeated dose of Δ9-tetrahydrocannabinol affects memory performance through serotonergic signalling in mice.. [DOI: 10.1101/2021.05.31.446448] [Reference Citation Analysis]
26 Pascual Cuadrado D, Wierczeiko A, Hewel C, Gerber S, Lutz B. Dichotomic Hippocampal Transcriptome After Glutamatergic vs. GABAergic Deletion of the Cannabinoid CB1 Receptor. Front Synaptic Neurosci 2021;13:660718. [PMID: 33897403 DOI: 10.3389/fnsyn.2021.660718] [Reference Citation Analysis]
27 Cottone E, Pomatto V, Rapelli S, Scandiffio R, Mackie K, Bovolin P. Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model. Molecules 2021;26:1448. [PMID: 33800024 DOI: 10.3390/molecules26051448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kayser RR, Haney M, Simpson HB. Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research. Front Psychiatry 2021;12:626150. [PMID: 33716825 DOI: 10.3389/fpsyt.2021.626150] [Reference Citation Analysis]
29 Santoro A, Mele E, Marino M, Viggiano A, Nori SL, Meccariello R. The Complex Interplay between Endocannabinoid System and the Estrogen System in Central Nervous System and Periphery. Int J Mol Sci 2021;22:972. [PMID: 33478092 DOI: 10.3390/ijms22020972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]